Apatinib for the treatment of gastric cancer.

INTRODUCTION Antiangiogenesis therapy plays an important role in cancer treatment. Apatinib mesylate, a small molecule tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, has been recommended as third-line treatment for metastatic gastric cancer patients. AREAS COVERED The current review summarizes the publications and… (More)